Accéder au contenu
Merck

Polarized actin and VE-cadherin dynamics regulate junctional remodelling and cell migration during sprouting angiogenesis.

Nature communications (2017-12-22)
Jiahui Cao, Manuel Ehling, Sigrid März, Jochen Seebach, Katsiaryna Tarbashevich, Tomas Sixta, Mara E Pitulescu, Ann-Cathrin Werner, Boris Flach, Eloi Montanez, Erez Raz, Ralf H Adams, Hans Schnittler
RÉSUMÉ

VEGFR-2/Notch signalling regulates angiogenesis in part by driving the remodelling of endothelial cell junctions and by inducing cell migration. Here, we show that VEGF-induced polarized cell elongation increases cell perimeter and decreases the relative VE-cadherin concentration at junctions, triggering polarized formation of actin-driven junction-associated intermittent lamellipodia (JAIL) under control of the WASP/WAVE/ARP2/3 complex. JAIL allow formation of new VE-cadherin adhesion sites that are critical for cell migration and monolayer integrity. Whereas at the leading edge of the cell, large JAIL drive cell migration with supportive contraction, lateral junctions show small JAIL that allow relative cell movement. VEGFR-2 activation initiates cell elongation through dephosphorylation of junctional myosin light chain II, which leads to a local loss of tension to induce JAIL-mediated junctional remodelling. These events require both microtubules and polarized Rac activity. Together, we propose a model where polarized JAIL formation drives directed cell migration and junctional remodelling during sprouting angiogenesis.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Fibrinogène from bovine plasma, Type I-S, 65-85% protein (≥75% of protein is clottable)
Sigma-Aldrich
Thrombine from bovine plasma, lyophilized powder, 40-300 NIH units/mg protein (biuret)
Sigma-Aldrich
Aprotinine from bovine lung, lyophilized powder, 3-8 TIU/mg solid
Sigma-Aldrich
DAPT, ≥98% (HPLC), solid
Sigma-Aldrich
Anticorps anti-α-tubuline monoclonal antibody produced in mouse, ascites fluid, clone B-5-1-2
Sigma-Aldrich
Nocodazole, ≥99% (TLC), powder
Sigma-Aldrich
Phalloïdine-isothiocyanate de tétraméthylrhodamine B, sequence from Amanita phalloides(synthetic: peptide sequence)
Sigma-Aldrich
MISSION® esiRNA, targeting human NRP1